Failure to Complete PASARR After New Mental Health Diagnosis and Antipsychotic Prescription
Penalty
Summary
The facility failed to ensure that a Preadmission Screening and Resident Review (PASARR) was completed when a resident received a new mental health diagnosis and was prescribed an antipsychotic medication. The clinical record review showed that the resident had multiple diagnoses, including dementia, anxiety disorder, depression, and later, a psychotic disorder with delusions due to a known physiological condition. The initial PASARR Level I indicated no need for a Level II review, as only anxiety disorder and depression were present at that time. However, after the resident was prescribed quetiapine, an antipsychotic medication, and received a new diagnosis of psychotic disorder with delusions, no updated PASARR screening was conducted. The Social Service Director confirmed that the PASARR did not reflect the new medication or diagnosis and acknowledged that another screen should have been implemented. Facility policy requires that a change in status, such as a new diagnosis or medication, triggers a Level II PASARR follow-up, which was not completed in this case.